Related Experiment Videos
Follow-up in 103 patients with catecholamine-secreting tumours
H Kreft1, G F Scheumann, A von zur Mühlen
1Abt. Endokrinologie und Stoffwechsel, FPP, Universität Trier, Friedrich Wilhelm-Str. 29, D-54290 Trier, Germany.
European Journal of Medical Research
|September 16, 1998
Summary
Surgery for catecholamine-secreting tumors improves patient well-being and corrects hypertension in most cases. Long-term follow-up shows sustained benefits, though some patients experience persistent symptoms or complications.
Area of Science:
- Endocrinology
- Surgical Oncology
Background:
- Catecholamine-secreting tumors, such as pheochromocytomas and paragangliomas, pose significant health risks.
- Surgical intervention is the primary treatment modality for these tumors.
Purpose of the Study:
- To evaluate the long-term outcomes and patient well-being following surgical resection of catecholamine-secreting tumors.
- To assess the resolution of hypertension and persistence of symptoms post-surgery.
Main Methods:
- A retrospective analysis of 103 patients who underwent surgery for catecholamine-secreting tumors.
- Follow-up investigation conducted 7.0 +/- 4.9 years post-surgery, assessing clinical outcomes, symptom persistence, and patient-reported well-being.
Main Results:
- 85% of patients reported improved general well-being post-surgery.
- Hypertension was corrected in 61%, but 26% remained hypertensive; 24% developed hypotension.
- Persistent symptoms included palpitations (16%), sweating (17%), headache (12%), and cardiac insufficiency (32%). Scar discomfort varied by surgical approach.
Conclusions:
- Surgical treatment of catecholamine-secreting tumors leads to significant improvements in health and well-being for the majority of patients.
- While hypertension is often resolved, a subset of patients may experience persistent endocrine-related symptoms or surgical complications.